Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

This is not the most recent version

view the current version 03 May 2022

Information

DOI:
https://doi.org/10.1002/14651858.CD004523Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 20 October 2003see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:

  1. Cochrane Musculoskeletal Group

Copyright:
  1. Copyright © 2005 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Ann Cranney

    Correspondence to: Division of Rheumatology, Clinical Epidemiology Program, The Ottawa Hospital, Ottawa Health Research Institute, Ottawa, Canada

    [email protected]

  • Jonathan D Adachi

    Department of Medicine, McMaster University, Hamilton, Canada

  • Gordon Guyatt

    Hamilton, Canada

  • Alexandra Papaioannou

    Chedoke‐McMaster Hospital, Hamilton, Canada

  • Vivian A Robinson

    Global Health, Institute of Population Health‐University of Ottawa, Ottawa, Canada

  • Beverley J Shea

    Institute of Population Health, University of Ottawa, Ottawa, Canada

  • Peter Tugwell

    Centre for Global Health, Institute of Population Health‐University of Ottawa, Ottawa, Canada

  • Lisa M. Waldegger

    Clinical Epidemiology Unit, Ottawa Health Research Institute, Ottawa, Canada

  • B Weaver

    Other

  • George Wells

    Department of Epidemiology and Community Medicine, Ottawa, Canada

  • Nicole Zytaruk

    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada

Contributions of authors

AC, NZ, LW, AP extracted data and contacted authors for additional data.

AC, JDA, GG, PT, GW, BS, VR, BW contributed expertise in methodology, content, interpretation of the review and biostatistics.

Sources of support

Internal sources

  • Ottawa Health Research Institute, Clinical Epidemiology, Canada.

  • Queen's University, Department of Medicine, Canada.

External sources

  • A. Cranney was supported by a Arthritis Society Junior Research Scholar and A. Papaioannou is a Ministry of Health Clinician Scientist, Canada.

Declarations of interest

None known.

Acknowledgements

The authors wish to acknowledge the members of the Osteoporosis Research Advisory Group (Clifford Rosen MD‐ Chair), Drs. John Bilezikian, Lorraine Fitzpatrick, Murray J Favus, Douglas Kiel, Robert Marcus, Eric Orwell and Thomas Schnitzer and Dennis Black for their content expertise on this project. We would like to thank Jessie McGowan, MLS for her expertise in designing the search strategy.

Version history

Published

Title

Stage

Authors

Version

2022 May 03

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Review

George A Wells, Shu-Ching Hsieh, Carine Zheng, Joan Peterson, Wenfei Liu, Shannon E Kelly, Peter Tugwell

https://doi.org/10.1002/14651858.CD004523.pub4

2008 Jan 23

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Review

George A Wells, Ann Cranney, Joan Peterson, Michel Boucher, Beverley Shea, Vivian Welch, Doug Coyle, Peter Tugwell

https://doi.org/10.1002/14651858.CD004523.pub3

2006 Jan 25

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Review

Ann Cranney, J D Adachi, G Guyatt, Alexandra Papaioannou, Vivian Robinson, Beverley Shea, Peter Tugwell, Lisa M. Waldegger, B Weaver, George A Wells, Nicole Zytaruk

https://doi.org/10.1002/14651858.CD004523.pub2

2003 Oct 20

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Review

Ann Cranney, Jonathan D Adachi, Gordon Guyatt, Alexandra Papaioannou, Vivian A Robinson, Beverley J Shea, Peter Tugwell, Lisa M. Waldegger, B Weaver, George Wells, Nicole Zytaruk

https://doi.org/10.1002/14651858.CD004523

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.